Phase 3 Irritable Bowel Syndrome Trial, Recruiting NCT07114055 Sponsor: Md. Hazrat Ali Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Phase 3 Irritable Bowel Syndrome Trial, Recruiting

NCT07114055
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older
  • You must have been diagnosed with a type of irritable bowel syndrome that mainly causes diarrhea (known as IBS-D), based on a specific set of recognised medical guidelines called the Rome IV criteria (confirm with trial site)

Who may not be able to join:

  • People who have certain warning signs such as anaemia (low red blood cells), unexplained weight loss, bleeding from the back passage, needing to go to the toilet at night, or a family history of bowel cancer
  • People who have had major surgery on their digestive system in the past
  • People who have a medical condition that affects their digestive system, such as poorly controlled diabetes, or an overactive or underactive thyroid
  • Women who are currently pregnant or breastfeeding
  • People who drive vehicles or operate machinery as part of their work, including aerial operators
  • People who currently misuse drugs or alcohol

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +8801710725424

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Md. Hazrat Ali
Registry
ClinicalTrials.gov
Start date
15 August 2025
Est. completion
1 July 2026

Where this trial is recruiting

Bangladesh

Primary endpoints

1. Improvement of diarrhea predominant IBS symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov